{"nct_id":"NCT02658890","title":"An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread","status":"COMPLETED","status_verified_date":"2023-08","start_date":"2016-04-14","start_date_type":"ACTUAL","primary_completion_date":"2021-10-26","primary_completion_date_type":"ACTUAL","completion_date":"2021-10-26","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["BMY"]}